Basic research in substantia nigra and ventral tegmental area: clinical implications.
In this review we will briefly examine some physiological and pharmacological aspects of the dopaminergic and non-dopaminergic cells of the midbrain in relationship to pathological conditions such as extrapyramidal disorders, mental illness, drug seeking behaviour and epilepsy.
Stratta
F
F
Università di Tor Vergata, Roma, Italy.
Bonci
A
A
Calabresi
P
P
Stefani
A
A
Pisani
A
A
Bernardi
G
G
Mercuri
N B
NB
D000818:Animals; D001480:Basal Ganglia Diseases / Q000188:drug therapy / Q000473:pathology / Q000503:physiopathology; D004298:Dopamine / Q000502:physiology*; D004827:Epilepsy / Q000188:drug therapy / Q000473:pathology / Q000503:physiopathology; D006801:Humans; D001523:Mental Disorders / Q000188:drug therapy / Q000473:pathology / Q000503:physiopathology; D010300:Parkinson Disease / Q000188:drug therapy / Q000473:pathology / Q000503:physiopathology; D019966:Substance-Related Disorders / Q000188:drug therapy / Q000473:pathology / Q000503:physiopathology; D013378:Substantia Nigra / Q000187:drug effects / Q000473:pathology / Q000503:physiopathology*; D017557:Ventral Tegmental Area / Q000187:drug effects / Q000473:pathology / Q000503:physiopathology*
D004298:Dopamine